Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

24

Number of overlapping holdings

10.7%

% of IBB's 261 holdings also in IBRN

64.9%

% of IBRN's 51 holdings also in IBB

Overlap by Weight
Sector Drift (IBB minus IBRN)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in IBB
Weight
in IBRN
Overlap
ARGENX SE ADR 2.7% 4.2% 2.7%
BIOGEN IDEC INC 2.1% 4.2% 2.1%
INTRA-CELLULAR THERAPIES INC 1.3% 6.8% 1.3%
NEUROCRINE BIOSCIENCES INC 1.1% 3.9% 1.1%
SAREPTA THERAPEUTICS INC 0.9% 3.5% 0.9%

Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to IBRN
GILEAD SCIENCES INC 10.6%
AMGEN INC 9.6%
VERTEX PHARMACEUTICALS INC 8.7%
REGENERON PHARMACEUTICALS 7.3%
IQVIA HOLDINGS INC 3.4%
ALNYLAM PHARMACEUTICALS INC 3.1%
METTLER-TOLEDO INTERNATIONAL 2.6%
WATERS CORP 2.3%
BIONTECH SE SPONSORED ADR 2.0%
NATERA INC 1.7%
IBB Underweight Relative to IBRN
INTRA-CELLULAR THERAPIES INC -5.6%
SK BIOPHARMACEUTICALS CO., LTD. -4.5%
PTC THERAPEUTICS INC -4.4%
CATALYST PHARMACEUTICAL PART -4.4%
ALKERMES PLC -4.3%
ACADIA PHARMACEUTICALS INC -4.2%
SUPERNUS PHARMACEUTICALS INC -3.8%
INTEGRA LIFESCIENCES HOLDING -3.7%
EDGEWISE THERAPEUTICS, INC. -3.6%
SCHOLAR ROCK HOLDING CORP. -3.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY